KOPRAN RES LAB LTD has a total of 25 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and chemical engineering are XSPRAY PHARMA AB PUBL, XSPRAY MICROPARTICLES AB and EUROFARMA LAB LTDA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | United States | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | India | 1 | |
#8 | Mexico | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars | |
#4 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Deshpande Jayant Venkatesh | 12 |
#2 | Ranbhan Kamlesh Jayantilal | 11 |
#3 | Gupte Rajan Vitthal | 9 |
#4 | Mali Subhash | 7 |
#5 | Ranbhan Kamlesh | 6 |
#6 | Mali Subhash Pandurang | 6 |
#7 | Gupte Rajan | 6 |
#8 | Sarangan Srinivasan | 6 |
#9 | Kadam Vaishali Madhukar | 6 |
#10 | Deshpande Jayant | 6 |
Publication | Filing date | Title |
---|---|---|
WO2007029266A2 | A process for preparing 9-deoxo-9a-aza-9a-homoerythromycin a | |
WO2007015265A2 | A process for preparing 6,9-imino ether | |
WO2007017898A2 | A process of recovery of pt/c catalyst in the preparation of azithromycin dihydrate | |
WO2007029265A2 | A process for preparing clarithromycin and clarithromycin intermediate | |
WO2005105153A1 | Hydroxyalkyl derivatives of biologically active compounds | |
AU2003300696A1 | Chemoenzymatically hydrolysable biologically active compounds | |
AU2003300695A8 | Reactive polymers having chemoenzymatically hydrolysable functional groups | |
ZA200206649B | Orally administrable acid stable anti-ulcer benzimidazole derivatives. | |
US2004028737A1 | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same | |
EP1311275A1 | A synthetic bulk laxative | |
AU5424500A | Orally administrable acid stable anti-ulcer benzimidazole derivatives |